BCAN Stock Overview
Develops and manufactures women’s wellness devices and services.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Femto Technologies Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$8.02 |
52 Week High | US$4,521.97 |
52 Week Low | US$7.83 |
Beta | 1.13 |
11 Month Change | -1.60% |
3 Month Change | -23.54% |
1 Year Change | -99.72% |
33 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -99.95% |
Recent News & Updates
Shareholder Returns
BCAN | US Software | US Market | |
---|---|---|---|
7D | -0.4% | -1.0% | 0.3% |
1Y | -99.7% | 28.3% | 32.4% |
Return vs Industry: BCAN underperformed the US Software industry which returned 30.5% over the past year.
Return vs Market: BCAN underperformed the US Market which returned 32.5% over the past year.
Price Volatility
BCAN volatility | |
---|---|
BCAN Average Weekly Movement | 8.1% |
Software Industry Average Movement | 7.6% |
Market Average Movement | 6.4% |
10% most volatile stocks in US Market | 15.0% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: BCAN has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: BCAN's weekly volatility has decreased from 22% to 8% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 8 | Yftah Ben Yaackov | cannasoft-crm.com |
Femto Technologies Inc. develops and manufactures women’s wellness devices and services. It offers its products for muscle relief and relaxation, redefining skin, and nurturing its hair, as well as sexual wellness devices. The company owns and markets Benefit customer relationship management (CRM), a proprietary customer relationship management software product that enables small and medium-sized enterprises to optimize day-to-day business activities.
Femto Technologies Inc. Fundamentals Summary
BCAN fundamental statistics | |
---|---|
Market cap | US$5.23m |
Earnings (TTM) | -US$34.74m |
Revenue (TTM) | US$825.25k |
6.3x
P/S Ratio-0.2x
P/E RatioIs BCAN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
BCAN income statement (TTM) | |
---|---|
Revenue | CA$1.12m |
Cost of Revenue | CA$927.46k |
Gross Profit | CA$192.63k |
Other Expenses | CA$47.34m |
Earnings | -CA$47.15m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -72.52 |
Gross Margin | 17.20% |
Net Profit Margin | -4,209.23% |
Debt/Equity Ratio | 0.8% |
How did BCAN perform over the long term?
See historical performance and comparison